Gene Page: ANKRD26
Summary ?
| GeneID | 22852 |
| Symbol | ANKRD26 |
| Synonyms | THC2|bA145E8.1 |
| Description | ankyrin repeat domain 26 |
| Reference | MIM:610855|HGNC:HGNC:29186|Ensembl:ENSG00000107890|HPRD:16491|Vega:OTTHUMG00000017851 |
| Gene type | protein-coding |
| Map location | 10p12.1 |
| Pascal p-value | 0.032 |
| Sherlock p-value | 0.669 |
| eGene | Cerebellum Meta |
Gene in Data Sources
| Gene set name | Method of gene set | Description | Info |
|---|---|---|---|
| CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
| Top 10 positively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| AFAP1 | 0.94 | 0.92 |
| WHSC1L1 | 0.94 | 0.94 |
| LATS1 | 0.94 | 0.93 |
| MYST3 | 0.93 | 0.94 |
| C14orf118 | 0.93 | 0.93 |
| ZNF281 | 0.93 | 0.95 |
| MED1 | 0.93 | 0.94 |
| ZNF518B | 0.93 | 0.93 |
| PHF20 | 0.93 | 0.94 |
| AL096711.2 | 0.93 | 0.93 |
| Top 10 negatively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| HSD17B14 | -0.70 | -0.80 |
| AF347015.31 | -0.69 | -0.84 |
| AIFM3 | -0.69 | -0.75 |
| FXYD1 | -0.68 | -0.84 |
| IFI27 | -0.68 | -0.83 |
| SERPINB6 | -0.68 | -0.70 |
| MT-CO2 | -0.67 | -0.84 |
| C5orf53 | -0.67 | -0.72 |
| HIGD1B | -0.66 | -0.84 |
| S100B | -0.66 | -0.78 |
Section V. Pathway annotation
| Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
|---|---|---|---|
| PUJANA BRCA1 PCC NETWORK | 1652 | 1023 | All SZGR 2.0 genes in this pathway |
| PUJANA ATM PCC NETWORK | 1442 | 892 | All SZGR 2.0 genes in this pathway |
| MOREAUX MULTIPLE MYELOMA BY TACI UP | 412 | 249 | All SZGR 2.0 genes in this pathway |
| SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1 | 419 | 273 | All SZGR 2.0 genes in this pathway |
| ZHANG BREAST CANCER PROGENITORS UP | 425 | 253 | All SZGR 2.0 genes in this pathway |
| WANG RESPONSE TO GSK3 INHIBITOR SB216763 UP | 397 | 206 | All SZGR 2.0 genes in this pathway |
| LEE BMP2 TARGETS DN | 882 | 538 | All SZGR 2.0 genes in this pathway |
| BILANGES SERUM SENSITIVE VIA TSC2 | 39 | 25 | All SZGR 2.0 genes in this pathway |
| TERAO AOX4 TARGETS SKIN UP | 38 | 27 | All SZGR 2.0 genes in this pathway |
| VANOEVELEN MYOGENESIS SIN3A TARGETS | 220 | 133 | All SZGR 2.0 genes in this pathway |